July 25, 2014 12:08 PM ET

Pharmaceuticals

Company Overview of Pathway Therapeutics Ltd.

Company Overview

Pathway Therapeutics Ltd. a drug development company, develops therapeutics against human diseases. It offers PI3 kinase, an enzyme identified as active in cancer tumor development. The company is based in San Francisco, California.

409 Illinois Street

San Francisco, CA 94158

United States

Founded in 2008

Key Executives for Pathway Therapeutics Ltd.

Chief Executive Officer
Age: 56
Vice President of Drug Discovery & Exploratory Development
Executive Director of Translational Medicine
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Invivis Pharmaceuticals Inc. United States
Performance Health, LLC United States
KAI Pharmaceuticals, Inc. United States
Hera Biomedical, Inc. United States
Mallinckrodt LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
September 10, 2013
Pathway Therapeutics Ltd., Worldwide Rights to PWT143
Merger/Acquisition
August 14, 2013
Pathway Therapeutics Ltd., Anticancer Drug
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pathway Therapeutics Ltd., please visit www.pathwaytx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.